Pancreatic Cancer Detection Consortium
Early Detection of Pancreatic Cancer: Prospective Study
- Pancreatic Cancer
- Pancreatic Carcinoma
- Pancreatic Adenocarcinoma
- Pancreatic Ductal Adenocarcinoma
- Pancreatic Neoplasms
- Pancreatic Cancer Stage I
- Pancreatic Cancer Stage
- Pancreatic Cancer Resectable
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- City of Hope Medical Center
- Enrolment target
- 2,000
- Started
- 15 March 2023
- Main results due
- 30 December 2030
- Study sites
- 13
- Registry updated
- 28 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- Healthy volunteers can take part.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Histological diagnosis of pancreatic ductal adenocarcinoma, stages I-IV (TNM classification, 8th edition) * Received standard diagnostic and staging procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment. * Imaging- or endoscopy-based proof of lack of pancreatic ductal adenocarcinoma at the time of sampling (Non-disease controls) Exclusion Criteria: * Lack of written informed consent.
What this study is about
In the sponsor’s own words, from the registry.
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
Study sites(13)
Translational Genomics Research Institute
Phoenix, Arizona, United States
Recruiting
Honorhealth
Scottsdale, Arizona, United States
Terminated
City of Hope Medical Center
Monrovia, California, United States
Recruiting
Hoag Center
Newport Beach, California, United States
Terminated
OSF HealthCare
Peoria, Illinois, United States
Recruiting
Ochsner Medical Center
Jefferson, Louisiana, United States
Recruiting
Atlantic Health System
Morristown, New Jersey, United States
Recruiting
AHN Cancer Institute at Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Recruiting
Piedmont Medical Center
Rock Hill, South Carolina, United States
Recruiting
MultiCare Cancer Institute - Tacoma General Hospital
Tacoma, Washington, United States
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting
Nagoya University
Nagoya, Japan
Recruiting
Asan Medical Center
Seoul, South Korea
Recruiting
Showing 13 of 13 sites. 11 of the 13 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06388967. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me